“Selective Serotonin Reuptake Inhibitors Response and the Impact of CYP2C19 Metabolizer Status”. Precision Medicine Communications, vol. 2, no. 1, June 2022, pp. 05-07, https://doi.org/10.55627/pmc.002.01.0097.